Mobile Menu Button
  • 03 Jan 18

Home Spirometry Is the Future of Monitoring Lung Disease Progression in LAM Patients

Home spirometry is being added as a secondary end point in a lymphangioleiomyomatosis (LAM) trial soon to begin enrollment at the University of Cincinnati (UC) Medical Center. Its inclusion is aimed at helping to assess the feasibility and reliability of performing home spirometry among patients with LAM. “Checking lung function more often will result in

Learn More →
  • 03 Jan 18

HRCT is Cost-Effective in Screening for Diffuse Cystic Lung Diseases in Patients Presenting with a Spontaneous Pneumothorax

“A strategy of performing high-resolution computed tomography [HRCT] scanning followed by pleurodesis is cost-effective in screening for the presence of diffuse cystic lung diseases (DCLDs) in patients who present with an apparent primary spontaneous pneumothorax (PSP),” said Nishant Gupta, MD, assistant professor of medicine and director of the Interstitial Lung Diseases Center, University of Cincinnati

Learn More →